Consensus Exelon Corporation

Equities

EXC

US30161N1019

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
37.66 ^USD	-0.29%		+2.67%	+4.90%

Apr. 23	Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating	MT
Apr. 22	Scotiabank Adjusts Exelon's Price Target to $37 From $39	MT

Evolution of the average Target Price on Exelon Corporation

Price target over the last 5 years

History of analyst recommendation changes

f57.Aq81MbvrUDsFFKSF9vf0hY_hFGzV_G7Dt9dYf_w0DW4.XeJXWsGRPBZDQ_LLxLuS3_WsdyO_jF_w0e4rPcoFVwVP919dw9M1bmJHww~385b3962d3e41d2c0c078f47194a05ab

Analyst Recommendations on Exelon Corporation

Morgan Stanley Adjusts Exelon's Price Target to $38 From $37, Keeps Equalweight Rating	Apr. 23	MT
Scotiabank Adjusts Exelon's Price Target to $37 From $39	Apr. 22	MT
BMO Capital Adjusts Exelon Price Target to $40 From $39	Apr. 22	MT
Barclays Adjusts Price Target on Exelon to $39 From $36, Maintains Overweight Rating	Mar. 14	MT
Wells Fargo Cuts Price Target on Exelon to $39 From $41, Maintains Equalweight Rating	Feb. 22	MT
Exelon beats Q4 profit estimates on higher electricity rates	Feb. 21	RE
Stocks Decline Pre-Bell as Fed Outlook, Rates Weigh; Asia Mixed, Europe Mostly Up	Feb. 21	MT
Barclays Cuts Price Target on Exelon to $36 From $38, Maintains Overweight Rating	Jan. 22	MT
BofA Adjusts Price Target on Exelon to $36 From $38, Keeps Neutral Rating	Jan. 19	MT
In wait-and-see mode	Jan. 10
Mizuho Securities Upgrades Exelon to Buy From Neutral, Raises Price Target to $39 From $36	Jan. 10	MT
ANALYST RECOMMENDATIONS : Apple, Block, Palo Alto, Wise, Workday...	Jan. 10
Seaport Downgrades Exelon to Neutral From Buy	Jan. 08	MT
UBS Downgrades Exelon to Neutral From Buy, Adjusts Price Target to $37 From $47	Jan. 02	MT
RBC Cuts Price Target on Exelon to $38 From $45 Amid Illinois Grid Plan Rejection, Keeps Sector Perform Rating	Dec. 19	MT
Exelon 2025 EPS Forecast Lowered by Morgan Stanley Following Illinois Regulator's Rate Case Decision	Dec. 18	MT
Mizuho Adjusts Exelon's Price Target to $36 From $40, Keeps Neutral Rating	Dec. 18	MT
JPMorgan Downgrades Exelon to Neutral From Overweight, Cuts Price Target to $41 From $46	Dec. 18	MT
Morgan Stanley Downgrades Exelon to Equalweight From Overweight, Cuts Price Target to $38 From $45 Amid 'Unfavorable' Illinois Rate Case Decision	Dec. 18	MT
ANALYST RECOMMENDATIONS : Abbvie, Blackrock, Chubb, JPMorgan, Salesforce...	Dec. 18
Evercore ISI Downgrades Exelon to In Line From Outperform	Dec. 15	MT
Guggenheim Downgrades Exelon to Neutral From Buy, Cuts Price Target to $40 From $44	Dec. 15	MT
Ameren Downgraded by KeyBanc to Sector Weight From Overweight Amid Disappointment Over Illinois Rate Case Decision	Dec. 15	MT
ANALYST RECOMMENDATIONS : Best Buy, Glencore, Lowe's, Nvidia, Clorox...	Nov. 22
Morgan Stanley Raises Price Target on Exelon to $43 From $42, Maintains Overweight Rating	Nov. 21	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

37.66 USD

Average target price

38.57 USD

Spread / Average Target

+2.42%

High Price Target

41.12 USD

Spread / Highest target

+9.19%

Low Price Target

36 USD

Spread / Lowest Target

-4.41%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Exelon Corporation

Morgan Stanley
Scotiabank
BMO Capital
Barclays
Wells Fargo Securities
BofA Securities
Mizuho Securities
Seaport Global Securities
UBS
RBC Capital Markets
JPMorgan Chase
Evercore ISI
Guggenheim
Credit Suisse
KeyBanc Capital Markets
Goldman Sachs
Argus
Vertical Research
Spin-Off Research
Wolfe Research

Ratings for Exelon Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar